Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Plegridy Market Value Growth And Long-Term Outlook
Growth during the historical period stemmed from a rise in multiple sclerosis diagnoses, the availability of interferon-based treatments, the expansion of neurology specialty clinics, an increase in injectable biologic therapies, and regulatory approvals for pegylated therapies.
The projected growth throughout the forecast period stems from the escalating demand for enhanced patient adherence solutions, increased investments in multiple sclerosis drug innovation, the expansion of personalized neurological care, a heightened focus on long-term disease management, and advancements in biologic drug delivery systems. Simultaneously, prominent trends anticipated during this period encompass the rising adoption of long-acting MS therapies, a growing call for treatments with reduced injection frequency, an intensified focus on disease-modifying therapies, the expansion of patient-centric treatment models, and improved monitoring of treatment outcomes.
Get A Free Sample Report With In-Depth Market Insights:
Plegridy Market Growth Drivers: What’s Behind The Acceleration?
The increasing prevalence of multiple sclerosis is anticipated to drive the future expansion of the plegridy market. Multiple sclerosis is a chronic autoimmune condition where the immune system mistakenly attacks myelin, the protective sheath around nerve fibers in the central nervous system, leading to impaired communication between the brain and body and causing various neurological symptoms. The rise in multiple sclerosis cases is attributed to a combination of environmental factors, enhanced diagnostic methods, greater awareness and recognition of the disease, and lifestyle factors such as obesity and vitamin D deficiency, particularly affecting women. Plegridy is utilized in patients with multiple sclerosis to decrease relapse rates and slow disease progression by modulating the immune system. For instance, in May 2024, a report by the Multiple Sclerosis Trust, a UK-based national charity, indicated that over 150,000 individuals in the UK live with multiple sclerosis, with new diagnoses increasing by over 7,100 annually. Furthermore, multiple sclerosis cases have grown by up to 15% across regions and are most frequently diagnosed in people in their 30s and 40s. Consequently, the rising prevalence of multiple sclerosis is fueling the growth of the plegridy market. The escalating healthcare spending is projected to propel the growth of the plegridy market going forward. Healthcare spending refers to the total funds allocated to healthcare goods and services, including personal health care, preventive measures, public health initiatives, and health administration, all aimed at improving health outcomes. This rise in healthcare expenditure is driven by population growth, an aging demographic, an increase in chronic illnesses, and higher costs for medical services and prescription drugs. Greater healthcare spending enhances plegridy’s market by expanding treatment access, boosting patient awareness, and supporting the necessary healthcare infrastructure for multiple sclerosis care. For instance, in August 2023, a report from the National Health Service Confederation, a UK-based membership organization, stated that in the 2022-23 fiscal year, the National Health Service (NHS) England received a total of $152.6 billion, with $107.8 billion, more than 70% of the total budget, being assigned to integrated care boards. Therefore, the increasing healthcare spending is driving the growth of the plegridy market.
Plegridy Market Segmentation: How Does The Market Break Down By Category?
The plegridy market covered in this report is segmented –
1) By Roue Of Administration: Subcutaneous (SC) Injection, Intramuscular (IM) Injection
2) By Clinical Indication: Relapsing-Remitting Multiple Sclerosis (RRMS), Secondary Progressive Multiple Sclerosis (SPMS) With Relapses
3) By Distribution Channel: Direct Sales, Online Pharmacies, Wholesale Distributors
4) By End User: Hospitals, Clinical Research Laboratories
Plegridy Market Competitive Overview And Top Companies
Major companies operating in the plegridy market are Biogen Inc.
View The Full Plegridy Market Report:
Plegridy Market Regional Analysis And Leading Geography
North America was the largest region in the plegridy market in 2025. The regions covered in the plegridy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
